Mutagenic activity of chemical carcinogens and related compounds in the intraperitoneal host-mediated assay. 1979

V F Simmon, and H S Rosenkranz, and E Zeiger, and L A Poirier

The mutagenic activities of 79 carcinogens, noncarcinogens, and structurally related compounds toward Salmonella typhimurium strains TA1530, TA1535, and TA1538 and toward Saccharomyces cerevisiae D3 were investigated in the intraperitoneal host-mediated assay. Fewer than half of the carcinogens were mutagenic toward the Salmonella strains. The insensitivity of the system was most marked with the aromatic amine and polycyclic hydrocarbon procarcinogens. Under the test conditions, fewer than 10% of the carcinogens showed clear mutagenic activity toward S. cerevisiae D3. However, none of the noncarcinogens was significantly mutagenic toward either S. typhimurium or S. cerevisiae D3. Overall, the intraperitoneal host-mediated assay does not seem suitable for routine preliminary screening of large numbers of potential carcinogens. The median lethal doses to mice of 46 compounds were determined.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009603 Nitroso Compounds Organic compounds containing the nitroso (-N Compounds, Nitroso
D011083 Polycyclic Compounds Compounds which contain two or more rings in their structure. Compounds, Polycyclic
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating
D000588 Amines A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amine

Related Publications

V F Simmon, and H S Rosenkranz, and E Zeiger, and L A Poirier
April 1979, Journal of the National Cancer Institute,
V F Simmon, and H S Rosenkranz, and E Zeiger, and L A Poirier
March 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
V F Simmon, and H S Rosenkranz, and E Zeiger, and L A Poirier
December 1977, Cancer research,
V F Simmon, and H S Rosenkranz, and E Zeiger, and L A Poirier
September 1977, Mutation research,
V F Simmon, and H S Rosenkranz, and E Zeiger, and L A Poirier
January 1982, Mutation research,
V F Simmon, and H S Rosenkranz, and E Zeiger, and L A Poirier
January 2005, Vestnik Rossiiskoi akademii meditsinskikh nauk,
V F Simmon, and H S Rosenkranz, and E Zeiger, and L A Poirier
May 1979, National Cancer Institute monograph,
V F Simmon, and H S Rosenkranz, and E Zeiger, and L A Poirier
August 1975, Mutation research,
V F Simmon, and H S Rosenkranz, and E Zeiger, and L A Poirier
January 1986, Voprosy onkologii,
V F Simmon, and H S Rosenkranz, and E Zeiger, and L A Poirier
January 1987, Archiv fur Geschwulstforschung,
Copied contents to your clipboard!